Correction to: Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab.

Johansson, Peter A; Stark, Andrew; Palmer, Jane M; Bigby, Kieron; Brooks, Kelly; Rolfe, Olivia; Pritchard, Antonia L; Whitehead, Kevin; Warrier, Sunil; Glasson, William; Hayward, Nicholas K

Johansson, Peter A; Stark, Andrew; Palmer, Jane M; Bigby, Kieron; Brooks, Kelly; Rolfe, Olivia; Pritchard, Antonia L; Whitehead, Kevin; Warrier, Sunil; Glasson, William; Hayward, Nicholas K.

Afiliación

Johansson PA; QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia. peter.johansson@qimrberghofer.edu.au.
Stark A; Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, QLD, Australia.
Palmer JM; QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Bigby K; Montserrat Cancer Care, North Lakes Day Hospital, North Lakes, QLD, Australia.
Brooks K; Redcliffe Hospital, Anzac Ave, Redcliffe, QLD, Australia.
Rolfe O; School of Medicine, University of Queensland, St Lucia, QLD, Australia.
Pritchard AL; QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Whitehead K; Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, QLD, Australia.
Warrier S; QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Glasson W; The University of the Highlands and Islands, Inverness, UK.
Hayward NK; Sullivan Nicolaides Pathology, Brisbane, QLD, Australia.

Immunogenetics ; 71(7): 511, 2019 Jul.

Article en En | MEDLINE | ID: mdl-31147739

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Immunogenetics Año: 2019 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google